Introduction {#Sec1}
============

Because approximately half of men and women experiencing sudden cardiac death do so without any prior clinical symptoms,[@CR1] how to best identify asymptomatic patients who are at risk for future cardiac events is an important medical issue. A Bayesian approach for the identification of CAD risk was initially developed by Diamond and Forrester,[@CR2] based on patients' age, sex, chest pain symptoms, and consideration of patients' CAD risk factors. Because middle aged and older asymptomatic patients with multiple CAD risk factors may have an intermediate (\>15%) Bayesian likelihood of CAD, they are not uncommonly referred for cardiac stress testing.[@CR3] Patients presenting with chest pain symptoms have an even higher Bayesian likelihood of CAD, which should thus place such patients at even higher risk for future cardiac events.[@CR4] Notably, however, comparisons of outcomes among patients with and without chest pain syndromes that have been referred for cardiac stress have revealed comparable event rates in some studies.[@CR5]-[@CR7] Heretofore, an explanation for these findings has been lacking. One possibility is that asymptomatic patients referred for cardiac stress testing may have a greater than suspected burden of subclinical atherosclerosis that places such patients at increased risk for cardiac events. New technologies such as coronary artery calcium (CAC) scanning allow us to test this hypothesis. Accordingly, in this study, we compared the presence and magnitude of subclinical atherosclerosis, as measured by CAC scanning in a cohort of asymptomatic patients referred for cardiac stress testing to that measured in a group of matched asymptomatic volunteers.

Methods {#Sec2}
=======

Study Cohort {#Sec3}
------------

The participants of this study included 136 asymptomatic patients (i.e., without chest pain symptoms), with a mean age of 59.2 ± 10.0, who were referred for exercise myocardial perfusion scintigraphy (MPS) at Cedars Sinai Medical Center (CSMC) by their referring physicians. These clinically referred patients underwent additional CAC scanning on a prospective research basis. Asymptomatic patients complaining of dyspnea were excluded,[@CR6] as were those with known CAD, cardiomyopathy, valvular disease, or those requiring pharmacologic stress testing. We separately evaluated a community cohort of 1,397 healthy asymptomatic volunteers who were recruited as part of a trial to assess the long-term impact of CAC scanning on subjects' health behaviors and risk profiles, the Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research (EISNER) trial. We preferentially recruited males, 45-80 years, or females 55-80 years, with one or more CAD risk factors. These volunteers underwent CAC scanning but not MPS. This research was approved by the CSMC Institutional Review Board and all subjects signed informed consent.

Clinical Information {#Sec4}
--------------------

At the time of testing, all patients completed a questionnaire regarding demographic information, chest pain symptoms, cardiac risk factors, and medication use. A Bayesian pre-MPS likelihood of CAD was calculated for each patient based on the analysis of age, gender, risk factors, chest pain symptoms, and results of exercise electrocardiography according to a previously validated commercial program (CADENZA).[@CR8] Fasting blood samples were obtained to assess total cholesterol, HDL cholesterol, and triglycerides, with calculated LDL cholesterol values. Serum glucose levels were assessed by a Cholestech (Hayward, CA, USA) desktop chemical analyzer. Weight and height were obtained on each subject for calculation of body mass index (BMI). Using the clinical and serum measures, a Framingham 10-year risk of cardiac death or nonfatal myocardial infarction was calculated for each subject in accordance with published guidelines.[@CR9]

Stress Testing and Imaging Protocol {#Sec5}
-----------------------------------

Following **s**ymptom-limited Bruce protocol exercise, patients underwent separate-acquisition-gated dual isotope MPS as previously described,[@CR10] with thallium-201(3.0-4.5 mCi) injected at rest and technetium-99m sestamibi (25-40 mCi) injected at near maximal exercise. An elliptical 180° acquisition and standard energy windows were used. Semi-quantitative visual interpretation was performed by experienced observers using a 5-point score for each of 20 myocardial segments and summed stress and rest scores were generated. Ischemia was defined by the presence of reversible defects in at least 5% of the myocardial segments.[@CR10]

Calcium Scanning {#Sec6}
----------------

Scanning was performed using either electron beam computed tomography (EBT) (Imatron C-150 or GE e-Speed) or multispiral computed tomography (MSCT) (Siemens Volume Zoom, Siemens Medical Systems). Each patient's scan consisted of approximately 30-40 slices of 3 or 2.5 mm for EBT and MSCT, respectively, with triggering at 50%-80% of the cardiac cycle. Foci of CAC were identified by an experienced technologist and scored using semi-automatic commercial software by detection of at least three contiguous pixels (voxel size = 1.03 mm^3^) of peak density ≥ 130 Hounsfield units within a coronary artery. CAC scores were calculated according to the method of Agatston et al[@CR11] Percentage CAC scores, based on age and gender, were assigned according to the database of Raggi et al[@CR12].

Statistical Analysis {#Sec7}
--------------------

Continuous variables were expressed as mean ± standard deviation and were compared using two-sample *t*-tests for normal data and two-sample Wilcoxon rank-sum test for nonnormal data. Normality was assessed by using Shapiro-Francia, Shapiro--Wilk, and Skewness/Kurtosis tests for normality. Because the distribution of CAC scores are highly skewed, in addition to its identity form, a transformation toward normality in the form of log(CAC + 1) was also used (adding one to deal with the 0 scores). Categorical variables were compared using the Pearson χ^2^ test; the χ^2^ test for trend and Fisher Exact test for cell counts \<6 were also used where appropriate. In order to adjust for differences in baseline characteristics between subjects and patients, all 136 were matched to the volunteer subjects on a 2:1 volunteer to patient ratio on the basis of age, gender, BMI, and history of the following coronary risk factors: high cholesterol, hypertension, smoking, diabetes, and family history of premature CAD. Matching was done using propensity scores that were derived from the predicted probabilities that resulted from a logistic regression model to predict being a patient vs being a subject.[@CR13] Since the matching was 2:1, the propensity matched groups were also compared as described above.

Results {#Sec8}
=======

Baseline Characteristics {#Sec9}
------------------------

A comparison of the clinical characteristics among the two study groups is shown in Table [1](#Tab1){ref-type="table"}. The healthy volunteers and patients were comparable in age but there were a greater percentage of males among the patients. The patient group had a higher frequency of high cholesterol, hypertension, diabetes, and higher glucose levels. Serum cholesterol and LDL levels were lower but lipid-lowering usage was greater among the patient cohort. Overall, all but 11 (8%) of our patient cohort had the presence of ≥1 CAD risk factors and 96 (71%) had ≥2 CAD risk factors.Table 1Clinical characteristics in the study groupsHealthy volunteers (N = 1,398)Asymptomatic patients (N = 136)*P*-valuesAge58.6 ± 8.659.2 ± 10.0.41Male739 (52.9%)104 (76.5%)\<.001CAD risk factors High cholesterol817 (58.4%)100 (73.5%).001 Hypertension583 (41.7%)74 (54.4%).004 Smoking91 (6.5%)11 (8.1%).48 Diabetes92 (6.6%)22 (16.2%)\<.001 Family history382 (27.3%)35 (25.7%).69 \# of CAD risk factors1.4 ± 0.91.7 ± 1.0\<.0001 BMI27.7 ± 5.328.2 ± 5.3.09 Pre-test likelihood of CAD6.7 ± 4.07.9 ± 4.7.001Medication use Blood pressure medications450 (32.2%)59 (43.4%).008 Lipid lowering medications364 (26.0%)56 (41.2%)\<.001Laboratory values Glucose96.1 ± 19.0101.2 ± 29.4.005 Cholesterol215.4 ± 41.6203.0 ± 47.6.0001 LDL135.6 ± 38.9124.1 ± 41.7.0002 HDL53.8 ± 16.651.5 ± 16.2.12 Triglycerides133.9 ± 84.4135.7 ± 104.3.35FRS Mean score11.0 ± 7.013.0 ± 8.2.01 FRS \< %10618 (56.0%)48 (42.9%) FRS 10%--20%319 (28.9%)37 (33.0%) FRS \> 20%167 (15.1%)27 (24.1%).01Resting hemodynamic Heart rate (bpm)66.3 ± 10.367.8 ± 12.10.22 Systolic BP (mmHg)133.1 ± 17.5135.3 ± 16.00.06 Diastolic BP (mmHg)82.0 ± 10.780.0 ± 8.00.005*BP*, Blood pressure.

Comparison of CAC Scores in the Asymptomatic Groups {#Sec10}
---------------------------------------------------

Table [2](#Tab2){ref-type="table"} lists the CAC findings in the two study groups. The mean CAC score was more than twofold higher in the patient group. More volunteers than patients had normal CAC scans and conversely, there was a substantially greater frequency of patients with very high CAC scores (i.e., \>1,000) compared to the volunteer group: 15.4% vs 2.9%, *P* \< .001. Similarly, the mean percentile CAC score was higher in the patient group and more patients than volunteers had a CAC percentile score ≥90%, *P* = .002.Table 2Results of CAC scanning in the study groupsHealthy volunteers (N = 1,398)Healthy volunteers (N = 1,398)Asymptomatic patients (N = 136)*P*-valuesMean CAC score122 ± 347394 ± 805\<.0001Mean log CAC score2.2 ± 2.43.5 ± 2.8\<.0001Distribution of CAC scores CAC = 0664 (47.5%)42 (30.9%) CAC 10--99416 (29.7%)37 (27.2%) CAC 100--399196 (14.0%)25 (18.4%) CAC 400--99987 (6.2%)11 (8.1%) CAC ≥ 100035 (2.5%)21 (15.4%)\<.001 CAC percentile33.2 ± 35.847.3 ± 37.9\<.0001 CAC \< 50th percentile873 (62.5%)66 (48.5%) CAC 50--74th percentiles257 (18.4%)25 (18.4%) CAC 75--89th percentiles160 (11.4%)19 (14.0%) CAC ≥ 90th percentile108 (7.7%)26 (19.1%)\<.001

Stress Test and Rest ECG Findings Among the Asymptomatic Patients {#Sec11}
-----------------------------------------------------------------

Among the 136 patients, the mean exercise duration was 9.6 ± 2.8 min, with a mean peak heart rate of 155 ± 13 bpm and mean peak systolic/diastolic blood pressure of 173/77 mmHg. An ischemic SPECT study was noted in 9 (7%) of the 136 patients, and in these patients, the mean CAC score was significantly higher than in the nonischemic SPECT patients (1616 ± 1182 vs 307 ± 700, *P* \< .0001). An ischemic SPECT occurred in only 2 (1.9%) of the patients with a CAC score \<1,000 but in 7 (27.0%) of the 26 patients with a CAC score ≥1,000 (*P* \< .0001).

Forty-five (33%) of the 136 patients had an abnormal ECG response during exercise testing, but of these 45, 42 (93%) had a normal exercise SPECT study, and the mean CAC score was not significantly different among the 42 nonischemic SPECT patients with an abnormal exercise ECG response vs the 88 nonischemic SPECT patients with a normal exercise ECG response (355 ± 581 vs 275 ± 755, *P* = .56).

We also repeated our analyses after excluding all patients manifesting an abnormal exercise ECG response. The substantial difference in mean CAC scores persisted in the remaining 91 asymptomatic patients compared to the healthy volunteers (385 ± 890 vs 122 ± 347, *P* \< .0001) as did the percent with CAC scores \>1,000 (13.2% vs 2.5%, *P* \< .0001).

Among the 136 referred patients, 40 (29%) had an abnormal rest ECG as an indicated reason for testing. The mean CAC score in this group was also not higher compared to those patients who had a normal resting ECG (279 ± 734 vs 413 ± 829, *P* \< .10). Other reasons for patient referral varied widely, including the referral of nine patients (7%) for pre-operative evaluation.

Comparison of the Volunteer and Patients Groups Following Propensity Analysis {#Sec12}
-----------------------------------------------------------------------------

Following a 2:1 propensity matching of the volunteer and patient groups on the basis of age, gender, and each of the major CAD risk factors (hypercholesterolemia, hypertension, smoking, diabetes, family history, and BMI), there were 272 propensity-matched volunteers and 136 propensity-matched patients. As shown in Table [3](#Tab3){ref-type="table"}, these two groups manifested no significant differences in age, gender distribution, CAD risk factors, medication use, Framingham risk score (FRS) scores, or pre-test likelihood of CAD. Serum chemistries differed only slightly (mildly lower cholesterol, LDL, and triglyceride values in the patient cohort).Table 3Clinical characteristics of the propensity-matched study groupsHealthy volunteers (N = 272)Asymptomatic patients (N = 136)*P*-valuesAge^a^58.5 ± 9.159.2 ± 10.0.43Male^a^207 (76.1%)104 (76.5%).93CAD risk factors High cholesterol^a^198 (72.8%)100 (73.5%).88 Hypertension^a^168 (61.8%)74 (54.4%).15 Smoking^a^14 (5.2%)11 (8.1%).24 Diabetes^a^40 (14.7%)22 (16.2%).70 Family history^a^64 (23.5%)35 (25.7%).62 \# of CAD factors1.8 ± 0.91.7 ± 1.0.82 BMI^a^28.4 ± 5.128.2 ± 5.3.65Medication use Blood pressure medications123 (45.2%)59 (43.4%).73 Lipid lowering medications99 (36.4%)56 (41.2%).35Laboratory values Glucose100.6 ± 22.4101.2 ± 29.4.67 Cholesterol211.5 ± 43.6203.0 ± 47.6.03 LDL133.6 ± 39.5124.1 ± 41.7.01 HDL50.4 ± 16.551.5 ± 16.2.32 Triglycerides140.9 ± 87.2135.7 ± 104.3.05FRS Mean score13.9 ± 8.313.0 ± 8.2.35 FRS \< 10%89 (42.8%)48 (42.9%) FRS 10%--20%61 (29.3%)37 (33.0%) FRS \> 20%58 (27.9%)27 (24.1%).70Resting hemodynamics Heart rate (bpm)66.5 ± 10.667.8 ± 12.1.39 Systolic BP (mmHg)137.1 ± 17.2135.3 ± 16.0.50 Diastolic BP (mmHg)85.8 ± 11.280.0 ± 8.0\<.0001^a^ Propensity-matched on these clinical risk factors.

Despite this propensity matching, the mean CAC score remained significantly higher in the patient group compared to the healthy volunteers (Table [4](#Tab4){ref-type="table"}). This difference in mean CAC scores within the propensity-matched subgroups was again due to a significantly greater percentage of patients with CAC scores \>1,000 compared to propensity-matched healthy volunteers (Figure [1](#Fig1){ref-type="fig"}).Table 4Results of CAC scanning in the propensity-matched study groupsHealthy volunteers (N = 272)Asymptomatic patients (N = 136)*P*-valuesMean CAC score152 ± 349394 ± 805.001Distribution of CAC scores CAC = 0111 (40.8%)42 (30.9%) CAC 1-924 (8.8%)9 (6.6%) CAC 10-9963 (23.2%)28 (20.6%) CAC 100-39934 (12.5%)25 (18.4%) CAC 400-99932 (11.8%)11 (8.1%) CAC ≥ 10008 (2.9%)21 (15.4%)\<.001 CAC percentile35.6 ± 35.447.3 ± 37.9.002 CAC \< 50th percentile165 (60.7%)66 (48.5%) CAC 50--74th percentiles55 (20.2%)25 (18.4%) CAC 75--89th percentile29 (10.7%)19 (14.0%) CAC ≥ 90th percentile23 (8.5%)26 (19.1%).008Figure 1Frequency of CAC scores \>1,000 (*y*-axis) among the 272 propensity-matched asymptomatic volunteers and 136 asymptomatic patients. A substantially greater frequency of CAC scores \>1,000 was noted within the patient group

Discussion {#Sec13}
==========

In this study, asymptomatic patients who were routinely referred for stress--rest myocardial perfusion SPECT were compared to a large group of asymptomatic individuals, recruited on a research basis as part of the EISNER study. In neither group was coronary calcium scanning used to determine the selection of subjects for study. Despite the absence of chest pain in both groups, the asymptomatic patients had a substantially greater mean CAC score, reflecting greater underlying atherosclerosis. This difference was due to a substantially greater concentration of patients with high CAC scores among the patient group. Nearly one-fourth of the asymptomatic patients had CAC scores \>400 and \~15% had CAC scores \>1,000. By contrast, \<3% of comparably aged healthy volunteers had CAC scores \>1,000.

Since the asymptomatic stress test patients were older, contained more males, and had a substantially greater frequency of CAD risk factors, we performed propensity matching to define a subgroup of volunteers and patients with the same risk factor profile. Because of our large volunteer population, we were able to perform this matching without excluding any patients. Among the propensity-matched subgroups, the greater frequency of patients with severe CAC scores (\>1,000) persisted among the patients compared to their matched controls.

Besides the presence of cardiac risk factors, patients are commonly referred for exercise SPECT because of an ischemic-appearing ECG response during treadmill exercise. In our study, approximately one-third of our asymptomatic patients had such abnormal responses. However, 93% of these abnormal ECG responses were associated with a normal exercise SPECT study, indicating that they probably represented false positive response for inducible myocardial ischemia in our patient population. We found that the magnitude of CAC was not significantly different among the nonischemic SPECT subgroups that manifested a normal vs abnormal ECG response during exercise testing. Moreover, excluding all patients with a positive exercise ECG response to exercise did not change the results of our study. Thus, other factors must be operative to explain our findings.

Potential Explanations for Increased Atherosclerosis in Asymptomatic Patients {#Sec14}
-----------------------------------------------------------------------------

Various mechanisms may have potentially contributed to the increased atherosclerosis among our asymptomatic patients. Potentially, our patients could have had increased severity of CAD risk factors, including a more severe family history of premature CAD. Alternatively, the chronicity of CAD risk factors could have been greater within our patient population. These potentially important data were not obtained in our study. In addition, other CAD factors not analyzed in our data could have served as intangible causes for increased cardiac risk, such as increase in Lp(a), small dense LDL, or homocysteine measurements. In addition, various noncoronary disease processes that help promote more fatigue, tension, and other somatic complaints that lead to physician visits could be preferentially operative in patient populations, including a higher frequency of inflammatory diseases such as arthritis and autoimmune disease,[@CR14],[@CR15] and more chronic stress or depression. These common conditions have been linked to various pathophysiological mechanisms that may interact synergistically with conventional CAD risk factors to promote accelerated atherosclerosis in patients.[@CR16],[@CR17] Prospective study is needed to assess these and other potential explanations for our findings.

Relevance to Prior Clinical Outcome Studies in Stress Test Populations {#Sec15}
----------------------------------------------------------------------

Among patients studied by planar thallium imaging in the 1980s,[@CR5] and then subsequently with SPECT imaging in the 1990s,[@CR6] we noted that asymptomatic patients had cardiac event rates which were comparable to patients with chest pain symptoms. Christopher Jones et al[@CR7] have noted similar findings among their stress test patients. In other study, we have observed that asymptomatic patients have a frequency of inducible myocardial ischemia that is comparable to that observed among symptomatic patients referred for stress testing.[@CR10] Our current findings suggest that a potential reason for these prior observations is the existence of clinically silent but substantial atherosclerotic burden among some asymptomatic patients. The higher risk of this subgroup is further suggested by our observation of a high rate of inducible myocardial ischemia in over one-fourth of our patients with CAC scores \>1,000. Of note, in prior studies involving a mixed cohort of patients with and without chest pain symptoms, a CAC score \>400 has been noted to serve as a threshold for observing increased myocardial ischemia,[@CR18],[@CR19] but pending further study, perhaps the CAC score threshold for ischemia may be higher in asymptomatic patients compared to those with chest pain symptoms.

Limitations {#Sec16}
-----------

Since our patient population was predominantly male, the role of gender could not be assessed in our study, nor did we assess the role of socioeconomic status or psychosocial risk factors. In addition, as aforementioned, knowledge concerning the temporal duration as well as the intensity of CAD risk factors may have been relevant to our results and would be useful parameters to assess in prospective studies comparing the presence and magnitude of coronary risk factors to measurements of atherosclerosis.

Clinical Relevance {#Sec17}
------------------

Multiple potential means exist for screening asymptomatic patients, including the use of global algorithms such as the FRS, Bayesian analysis of CAD likelihood, the use of cardiac stress testing, and more recently, the application of CAC scanning. Recent study has defined limitations of relying on the FRS score to screen for underlying CAD[@CR20] and in our study there was no difference between FRS in our matched volunteers and asymptomatic patients, despite the presence of more atherosclerosis in the latter group. Similarly, a limitation to Bayesian analysis is that it was developed for the prediction of angiographically significant CAD (i.e., \>50% cross-luminal narrowing) and thus may not be a good predictor of atherosclerosis, per se. Indeed, the Bayesian likelihood of CAD was also comparable in our matched volunteers and patients. Also pointing to the limitation of Bayesian analysis for screening purposes is recent data indicating a poor correlation between Bayesian estimates of CAD likelihood and measurement of CAC scores.[@CR21] In addition, our study offers fresh insight regarding the limitation of using stress testing to screen for underlying disease among asymptomatic patients. That is, the application of SPECT imaging in our patients yielded only 7% with ischemic responses, compared to 70% with evidence of atherosclerosis by CAC scanning, representing a wide differential of individuals identified at risk. However, since the induction of inducible myocardial ischemia has been shown to be uncommon among patients with CAC scores \<400,[@CR18],[@CR19] an approach that first uses CAC scanning might serve as a useful means of both narrowing and improving the selection of asymptomatic patients for subsequent cardiac stress testing. While the cost-effectiveness of such an approach needs to be prospectively evaluated, a recent study has suggested that the application of CAC scanning has the potential to reduce health costs by virtue of selectively concentrating downstream medical testing among asymptomatic subjects with higher CAC scores.[@CR22]

Conclusions {#Sec18}
===========

Compared to asymptomatic volunteers, asymptomatic patients with comparably matched CAD risk factor profiles contain substantially more individuals with severe, clinically undetected atherosclerosis, as evidenced by CAC scores \>1,000. This observation may help explain the results of outcome studies that have found overlapping cardiac event rates among asymptomatic vs symptomatic patients referred for cardiac stress testing. Prospective study is warranted to test the use of CAC scanning as a cost-effective triaging tool for the work-up of asymptomatic patients.
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